Home › Companies › CYTEK BIOSCIENCES INC. › 2024-2025
Compiled from SEC Form N-PX filings and CYTEK BIOSCIENCES INC.’s Form 8-K, filed 2025-06-24 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore CYTEK BIOSCIENCES INC. in the interactive database Compare manager voting policies
These tallies are CYTEK BIOSCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-24 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Richard Chin, MD | 81,794,582 | -- | -- | 208,499 | 21,866,390 | Majority: yes |
| Elect Director: Deborah Neff | 33,819,367 | -- | -- | 48,183,714 | 21,866,390 | Plurality election |
| Proposal 2: Executive Compensation. On a non-binding, advisory basis, the compensation paid to the Company's named executive officers for the year ended December 31, 2024 was approved based on the following results of voting: | 76,368,883 | 5,630,057 | 4,141 | -- | 21,866,390 | Majority: yes |
| Proposal 3: Ratification of the Selection of Independent Registered Public Accounting Firm. The selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 was ratified based on | 95,862,612 | 7,657,004 | 349,855 | -- | -- | Majority: yes |
Source: CYTEK BIOSCIENCES INC., Form 8-K, filed with the SEC on 2025-06-24 — read the filing on EDGAR.
Each item below shows how the 166 asset managers that disclosed a CYTEK BIOSCIENCES INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Meeting held 2025-06-18.
Combines 7 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
CYTEK BIOSCIENCES INC.’s own tally for this item (“Proposal 2: Executive Compensation. On a non-binding, advisory basis, the compensation paid to the Company's named executive officers for the year ended December 31, 2024 was approved based on the following results of vo”): 76,368,883 for, 5,630,057 against, per its Form 8-K filed 2025-06-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 126,659,196 outstanding shares: 60% for, 4% against (65% of the company cast a for/against vote).
The 164 asset managers below cast 91% of the shares they voted on this item FOR (61,809,029 for, 6,427,128 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 16,497,011 | 0 | 0 | 0 | For |
| Vanguard | 9,697,241 | 3,921 | 0 | 0 | For |
| HHLR ADVISORS, LTD. | 6,657,030 | 0 | 0 | 0 | For |
| State Street | 5,302,231 | 0 | 0 | 0 | For |
| BROWN CAPITAL MANAGEMENT LLC | 0 | 3,530,341 | 0 | 0 | Against |
| Fidelity | 2,858,470 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,711,039 | 0 | 0 | 0 | For |
| NEW YORK STATE COMMON RETIREMENT FUND | 2,088,390 | 0 | 0 | 0 | For |
| Charles Schwab | 2,060,862 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 0 | 2,054,970 | 0 | 0 | Against |
| Northern Trust | 983,388 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 751,745 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 738,703 | 0 | 0 | 0 | For |
| Royce | 730,819 | 0 | 0 | 0 | For |
| Goldman Sachs | 619,770 | 0 | 0 | 0 | For |
| JPMorgan | 563,449 | 0 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 521,233 | 0 | 0 | 0 | For |
| Impresa Management LLC | 517,790 | 0 | 0 | 0 | For |
| American Century | 475,364 | 0 | 0 | 0 | For |
| Dimensional | 440,218 | 0 | 0 | 0 | For |
| Nationwide | 116,364 | 264,509 | 0 | 0 | Against |
| Equitable | 343,929 | 0 | 0 | 0 | For |
| Nuveen | 304,985 | 0 | 0 | 0 | For |
| TIAA | 301,819 | 0 | 0 | 0 | For |
| GLOBEFLEX CAPITAL L P | 290,511 | 0 | 0 | 0 | For |
Showing the 25 largest of 164 asset managers. See all 164 in the interactive database.
Meeting held 2025-06-18.
Combines 5 wordings of this item as funds reported it.
41% Plurality election · of votes cast
CYTEK BIOSCIENCES INC.’s own tally for this item (“Elect Director: Deborah Neff”): 33,819,367 for, 48,183,714 withheld, per its Form 8-K filed 2025-06-24 (Item 5.07). This is a for/withhold election, which is decided by plurality: a nominee does not need a majority of the votes cast to be elected, so no passed or failed outcome is stated here. Of all 126,659,196 outstanding shares: 27% for, 38% withheld (65% of the company cast a for/withheld vote).
The 59 asset managers below cast 100% of the shares they voted on this item FOR (7,060,272 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 0 | 0 | 12,475,286 | 0 | Abstain |
| Vanguard | 9,710 | 0 | 9,415,212 | 0 | Abstain |
| Fidelity | 2,606,140 | 0 | 50,938 | 0 | For |
| Brown Capital Management Mutual Funds | 2,054,970 | 0 | 0 | 0 | For |
| State Street | 3,251 | 0 | 1,504,786 | 0 | Abstain |
| Charles Schwab | 970,255 | 0 | 0 | 0 | For |
| Royce | 720,279 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 0 | 490,680 | 0 | Abstain |
| Nationwide | 270,948 | 0 | 109,925 | 0 | For |
| Equitable | 0 | 0 | 343,929 | 0 | Abstain |
| TIAA | 301,819 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 0 | 258,590 | 0 | Abstain |
| American Century | 0 | 0 | 237,682 | 0 | Abstain |
| JPMorgan | 0 | 0 | 214,445 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 209,784 | 0 | Abstain |
| Jackson National | 0 | 0 | 205,542 | 0 | Abstain |
| Lincoln Financial | 0 | 0 | 171,673 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 117,626 | 0 | Abstain |
| TIFF INVESTMENT PROGRAM | 0 | 0 | 115,896 | 0 | Abstain |
| BNY Mellon | 0 | 0 | 115,686 | 0 | Abstain |
| Prudential/PGIM | 96,257 | 0 | 17,830 | 0 | For |
| Brighthouse | 0 | 0 | 102,565 | 0 | Abstain |
| Principal | 0 | 0 | 101,339 | 0 | Abstain |
| Empower | 0 | 0 | 88,987 | 0 | Abstain |
| Thrivent | 0 | 0 | 76,638 | 0 | Abstain |
Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.
Meeting held 2025-06-18.
Combines 5 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
CYTEK BIOSCIENCES INC.’s own tally for this item (“Elect Director: Richard Chin, MD”): 81,794,582 for, 208,499 withheld, per its Form 8-K filed 2025-06-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 126,659,196 outstanding shares: 65% for, 0.2% withheld (65% of the company cast a for/withheld vote).
The 59 asset managers below cast 100% of the shares they voted on this item FOR (34,191,253 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 12,475,286 | 0 | 0 | 0 | For |
| Vanguard | 9,421,009 | 0 | 3,913 | 0 | For |
| Fidelity | 2,657,078 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 2,054,970 | 0 | 0 | 0 | For |
| State Street | 1,508,037 | 0 | 0 | 0 | For |
| Charles Schwab | 970,255 | 0 | 0 | 0 | For |
| Royce | 720,279 | 0 | 0 | 0 | For |
| Goldman Sachs | 490,680 | 0 | 0 | 0 | For |
| Nationwide | 380,873 | 0 | 0 | 0 | For |
| Equitable | 343,929 | 0 | 0 | 0 | For |
| TIAA | 301,819 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 258,590 | 0 | 0 | 0 | For |
| American Century | 237,682 | 0 | 0 | 0 | For |
| JPMorgan | 214,445 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 209,784 | 0 | 0 | 0 | For |
| Jackson National | 205,542 | 0 | 0 | 0 | For |
| Lincoln Financial | 171,673 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 117,626 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 115,896 | 0 | 0 | 0 | For |
| BNY Mellon | 115,686 | 0 | 0 | 0 | For |
| Prudential/PGIM | 114,087 | 0 | 0 | 0 | For |
| Brighthouse | 102,565 | 0 | 0 | 0 | For |
| Principal | 101,339 | 0 | 0 | 0 | For |
| Empower | 88,987 | 0 | 0 | 0 | For |
| Thrivent | 76,638 | 0 | 0 | 0 | For |
Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.
Meeting held 2025-06-18.
Combines 2 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
CYTEK BIOSCIENCES INC.’s own tally for this item (“Proposal 3: Ratification of the Selection of Independent Registered Public Accounting Firm. The selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending”): 95,862,612 for, 7,657,004 against, per its Form 8-K filed 2025-06-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 126,659,196 outstanding shares: 76% for, 6% against (82% of the company cast a for/against vote).
The 59 asset managers below cast 99.8% of the shares they voted on this item FOR (34,157,430 for, 37,736 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 12,475,286 | 0 | 0 | 0 | For |
| Vanguard | 9,424,915 | 7 | 0 | 0 | For |
| Fidelity | 2,657,078 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 2,054,970 | 0 | 0 | 0 | For |
| State Street | 1,507,459 | 578 | 0 | 0 | For |
| Charles Schwab | 970,255 | 0 | 0 | 0 | For |
| Royce | 720,279 | 0 | 0 | 0 | For |
| Goldman Sachs | 490,680 | 0 | 0 | 0 | For |
| Nationwide | 356,573 | 24,300 | 0 | 0 | For |
| Equitable | 343,929 | 0 | 0 | 0 | For |
| TIAA | 301,819 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 258,590 | 0 | 0 | 0 | For |
| American Century | 237,682 | 0 | 0 | 0 | For |
| JPMorgan | 214,445 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 209,784 | 0 | 0 | 0 | For |
| Jackson National | 205,542 | 0 | 0 | 0 | For |
| Lincoln Financial | 171,673 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 117,626 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 115,896 | 0 | 0 | 0 | For |
| BNY Mellon | 115,686 | 0 | 0 | 0 | For |
| Prudential/PGIM | 114,087 | 0 | 0 | 0 | For |
| Brighthouse | 102,565 | 0 | 0 | 0 | For |
| Principal | 101,339 | 0 | 0 | 0 | For |
| Empower | 88,987 | 0 | 0 | 0 | For |
| Thrivent | 76,638 | 0 | 0 | 0 | For |
Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.
Meeting held 2024-06-05 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).
Combines 2 wordings of this item as funds reported it.
86% Majority: yes · of votes cast
CYTEK BIOSCIENCES INC.’s own tally for this item (“Proposal 2: Executive Compensation. On an advisory basis, compensation paid to the Company's named executive officers for the year ended December 31, 2023 was approved based on the following results of voting:”): 63,537,386 for, 10,476,039 against, per its Form 8-K filed 2024-06-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 126,659,196 outstanding shares: 50.2% for, 8% against (58% of the company cast a for/against vote).
The 2 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 1,587 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| COLDSTREAM CAPITAL MANAGEMENT INC | 0 | 1,587 | 0 | 0 | Against |
| Echo45 Advisors LLC | 0 | 0 | 0 | 0 | -- |
Ranked by the number of CYTEK BIOSCIENCES INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 126,659,196 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 13.02% |
| 2 | Vanguard | 7.66% |
| 3 | HHLR ADVISORS, LTD. | 5.26% |
| 4 | State Street | 4.19% |
| 5 | BROWN CAPITAL MANAGEMENT LLC | 2.79% |
| 6 | Fidelity | 2.26% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 2.14% |
| 8 | NEW YORK STATE COMMON RETIREMENT FUND | 1.65% |
| 9 | Charles Schwab | 1.63% |
| 10 | Brown Capital Management Mutual Funds | 1.62% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Entities affiliated with BlackRock, Inc. | 14.59% | DEF14A |
| BlackRock | 14.27% | 13F |
| Entities affiliated with The Vanguard Group | 9.39% | DEF14A |
| Vanguard Group | 7.60% | 13F |
| Entities affiliated with Brown Capital Management, LLC | 7.50% | DEF14A |
| Millennium Management LLC | 6.22% | 13G |
| Topline Capital Management, LLC | 5.35% | 13G |
| Entities affiliated with Hillhouse Investment Management, Ltd. | 5.26% | DEF14A |
| Ming Yan, Ph.D. | 5.02% | DEF14A |
| Wenbin Jiang, Ph.D. | 4.81% | DEF14A |
Percentages above are of 126,659,196 shares outstanding, as reported by CYTEK BIOSCIENCES INC. on its Form 10-Q dated 2025-04-30 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CYTEK BIOSCIENCES INC.’s 10-Q dated 2025-04-30. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At CYTEK BIOSCIENCES INC.'s shareholder meeting held 2025-06-18, in the 2024-2025 proxy season, 166 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 895 separate fund positions. On the most widely held item on that ballot — TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS… — FOR was 93% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: CYTEK BIOSCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-24.
CYTEK BIOSCIENCES INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.